The ADMA Biologics (NASDAQ:ADMA) stock continued on its losing streak on Wednesday as it declined by another 9% and took its decline for the past month to as much as 20%. The stock managed to record decline for six straight trading sessions and the miseries for the ADMA stock were further compounded after the firm …
Continue reading “ADMA Biologics (NASDAQ:ADMA) Stock Extends Fall: Down 20% in a Week”